Cargando…

Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic

OBJECTIVE: We conducted an international survey of patients with SLE to assess their access, preference and trust in various health information sources pre-COVID-19 and during the COVID-19 pandemic. METHODS: Patients with SLE were recruited from 18 observational cohorts, and patients self-reporting...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardwell, Francesca S, Elliott, Susan J, Chin, Ricky, St Pierre, Yvan, Choi, May Y, Urowitz, Murray B, Ruiz-Irastorza, Guillermo, Bernatsky, Sasha, Wallace, Daniel J, Petri, Michelle A, Manzi, Susan, Bae, Sang-Cheol, Shin, Jung-Min, Mak, Anselm, Cho, Jiacai, Peschken, Christine A, Ramsey-Goldman, Rosalind, Fortin, Paul R, Hanly, John G, Pons-Estel, Bernardo A, Nieto, Romina, Askanase, Anca D, Romero-Diaz, Juanita, Mosca, Marta, Bruce, Ian N, Rowbottom, Leigha, Mielczarek, Leanne, Tse, Karin, Marion, Ashley, Cáhiz-González, Juan Carlos, Cattoni, Teresa G, Cornet, Alain, Clarke, Ann Elaine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606736/
https://www.ncbi.nlm.nih.gov/pubmed/36283746
http://dx.doi.org/10.1136/lupus-2022-000755
_version_ 1784818363532312576
author Cardwell, Francesca S
Elliott, Susan J
Chin, Ricky
St Pierre, Yvan
Choi, May Y
Urowitz, Murray B
Ruiz-Irastorza, Guillermo
Bernatsky, Sasha
Wallace, Daniel J
Petri, Michelle A
Manzi, Susan
Bae, Sang-Cheol
Shin, Jung-Min
Mak, Anselm
Cho, Jiacai
Peschken, Christine A
Ramsey-Goldman, Rosalind
Fortin, Paul R
Hanly, John G
Pons-Estel, Bernardo A
Nieto, Romina
Askanase, Anca D
Romero-Diaz, Juanita
Mosca, Marta
Bruce, Ian N
Rowbottom, Leigha
Mielczarek, Leanne
Tse, Karin
Marion, Ashley
Cáhiz-González, Juan Carlos
Cattoni, Teresa G
Cornet, Alain
Clarke, Ann Elaine
author_facet Cardwell, Francesca S
Elliott, Susan J
Chin, Ricky
St Pierre, Yvan
Choi, May Y
Urowitz, Murray B
Ruiz-Irastorza, Guillermo
Bernatsky, Sasha
Wallace, Daniel J
Petri, Michelle A
Manzi, Susan
Bae, Sang-Cheol
Shin, Jung-Min
Mak, Anselm
Cho, Jiacai
Peschken, Christine A
Ramsey-Goldman, Rosalind
Fortin, Paul R
Hanly, John G
Pons-Estel, Bernardo A
Nieto, Romina
Askanase, Anca D
Romero-Diaz, Juanita
Mosca, Marta
Bruce, Ian N
Rowbottom, Leigha
Mielczarek, Leanne
Tse, Karin
Marion, Ashley
Cáhiz-González, Juan Carlos
Cattoni, Teresa G
Cornet, Alain
Clarke, Ann Elaine
author_sort Cardwell, Francesca S
collection PubMed
description OBJECTIVE: We conducted an international survey of patients with SLE to assess their access, preference and trust in various health information sources pre-COVID-19 and during the COVID-19 pandemic. METHODS: Patients with SLE were recruited from 18 observational cohorts, and patients self-reporting SLE were recruited through five advocacy organisations. Respondents completed an online survey from June 2020 to December 2021 regarding the sources of health information they accessed in the 12 months preceding (pre-11 March 2020) and during (post-11 March 2020) the pandemic. Multivariable logistic regressions assessed factors associated with accessing news and social media post-11 March 2020, and self-reporting negative impacts from health information accessed through these sources. RESULTS: Surveys were completed by 2111 respondents; 92.8% were female, 76.6% had postsecondary education, mean (SD) age was 48.8 (14.0) years. Lupus specialists and family physicians were the most preferred sources pre-11 March 2020 and post-11 March 2020, yet were accessed less frequently (specialists: 78.5% pre vs 70.2% post, difference −8.3%, 95% CI −10.2% to −6.5%; family physicians: 57.1% pre vs 50.0% post, difference −7.1%, 95% CI −9.2% to −5.0%), while news (53.2% pre vs 62.1% post, difference 8.9%, 95% CI 6.7% to 11.0%) and social media (38.2% pre vs 40.6% post, difference 2.4%, 95% CI 0.7% to 4.2%) were accessed more frequently post-11 March 2020 vs pre-11 March 2020. 17.2% of respondents reported negative impacts from information accessed through news/social media. Those outside Canada, older respondents or with postsecondary education were more likely to access news media. Those in Asia, Latin America or younger respondents were more likely to access social media. Those in Asia, older respondents, males or with postsecondary education in Canada, Asia or the USA were less likely to be negatively impacted. CONCLUSIONS: Physicians, the most preferred and trusted sources, were accessed less frequently, while news and social media, less trusted sources, were accessed more frequently post-11 March 2020 vs pre-11 March 2020. Increasing accessibility to physicians, in person and virtually, may help reduce the consequences of accessing misinformation/disinformation.
format Online
Article
Text
id pubmed-9606736
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-96067362022-10-27 Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic Cardwell, Francesca S Elliott, Susan J Chin, Ricky St Pierre, Yvan Choi, May Y Urowitz, Murray B Ruiz-Irastorza, Guillermo Bernatsky, Sasha Wallace, Daniel J Petri, Michelle A Manzi, Susan Bae, Sang-Cheol Shin, Jung-Min Mak, Anselm Cho, Jiacai Peschken, Christine A Ramsey-Goldman, Rosalind Fortin, Paul R Hanly, John G Pons-Estel, Bernardo A Nieto, Romina Askanase, Anca D Romero-Diaz, Juanita Mosca, Marta Bruce, Ian N Rowbottom, Leigha Mielczarek, Leanne Tse, Karin Marion, Ashley Cáhiz-González, Juan Carlos Cattoni, Teresa G Cornet, Alain Clarke, Ann Elaine Lupus Sci Med Epidemiology and Outcomes OBJECTIVE: We conducted an international survey of patients with SLE to assess their access, preference and trust in various health information sources pre-COVID-19 and during the COVID-19 pandemic. METHODS: Patients with SLE were recruited from 18 observational cohorts, and patients self-reporting SLE were recruited through five advocacy organisations. Respondents completed an online survey from June 2020 to December 2021 regarding the sources of health information they accessed in the 12 months preceding (pre-11 March 2020) and during (post-11 March 2020) the pandemic. Multivariable logistic regressions assessed factors associated with accessing news and social media post-11 March 2020, and self-reporting negative impacts from health information accessed through these sources. RESULTS: Surveys were completed by 2111 respondents; 92.8% were female, 76.6% had postsecondary education, mean (SD) age was 48.8 (14.0) years. Lupus specialists and family physicians were the most preferred sources pre-11 March 2020 and post-11 March 2020, yet were accessed less frequently (specialists: 78.5% pre vs 70.2% post, difference −8.3%, 95% CI −10.2% to −6.5%; family physicians: 57.1% pre vs 50.0% post, difference −7.1%, 95% CI −9.2% to −5.0%), while news (53.2% pre vs 62.1% post, difference 8.9%, 95% CI 6.7% to 11.0%) and social media (38.2% pre vs 40.6% post, difference 2.4%, 95% CI 0.7% to 4.2%) were accessed more frequently post-11 March 2020 vs pre-11 March 2020. 17.2% of respondents reported negative impacts from information accessed through news/social media. Those outside Canada, older respondents or with postsecondary education were more likely to access news media. Those in Asia, Latin America or younger respondents were more likely to access social media. Those in Asia, older respondents, males or with postsecondary education in Canada, Asia or the USA were less likely to be negatively impacted. CONCLUSIONS: Physicians, the most preferred and trusted sources, were accessed less frequently, while news and social media, less trusted sources, were accessed more frequently post-11 March 2020 vs pre-11 March 2020. Increasing accessibility to physicians, in person and virtually, may help reduce the consequences of accessing misinformation/disinformation. BMJ Publishing Group 2022-10-25 /pmc/articles/PMC9606736/ /pubmed/36283746 http://dx.doi.org/10.1136/lupus-2022-000755 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology and Outcomes
Cardwell, Francesca S
Elliott, Susan J
Chin, Ricky
St Pierre, Yvan
Choi, May Y
Urowitz, Murray B
Ruiz-Irastorza, Guillermo
Bernatsky, Sasha
Wallace, Daniel J
Petri, Michelle A
Manzi, Susan
Bae, Sang-Cheol
Shin, Jung-Min
Mak, Anselm
Cho, Jiacai
Peschken, Christine A
Ramsey-Goldman, Rosalind
Fortin, Paul R
Hanly, John G
Pons-Estel, Bernardo A
Nieto, Romina
Askanase, Anca D
Romero-Diaz, Juanita
Mosca, Marta
Bruce, Ian N
Rowbottom, Leigha
Mielczarek, Leanne
Tse, Karin
Marion, Ashley
Cáhiz-González, Juan Carlos
Cattoni, Teresa G
Cornet, Alain
Clarke, Ann Elaine
Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic
title Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic
title_full Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic
title_fullStr Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic
title_full_unstemmed Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic
title_short Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic
title_sort health information use by patients with systemic lupus erythematosus (sle) pre and during the covid-19 pandemic
topic Epidemiology and Outcomes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606736/
https://www.ncbi.nlm.nih.gov/pubmed/36283746
http://dx.doi.org/10.1136/lupus-2022-000755
work_keys_str_mv AT cardwellfrancescas healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT elliottsusanj healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT chinricky healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT stpierreyvan healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT choimayy healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT urowitzmurrayb healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT ruizirastorzaguillermo healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT bernatskysasha healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT wallacedanielj healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT petrimichellea healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT manzisusan healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT baesangcheol healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT shinjungmin healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT makanselm healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT chojiacai healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT peschkenchristinea healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT ramseygoldmanrosalind healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT fortinpaulr healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT hanlyjohng healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT ponsestelbernardoa healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT nietoromina healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT askanaseancad healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT romerodiazjuanita healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT moscamarta healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT bruceiann healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT rowbottomleigha healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT mielczarekleanne healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT tsekarin healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT marionashley healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT cahizgonzalezjuancarlos healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT cattoniteresag healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT cornetalain healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic
AT clarkeannelaine healthinformationusebypatientswithsystemiclupuserythematosusslepreandduringthecovid19pandemic